Painful Non‐Diabetic Lumbosacral Radiculoplexus Neuropathy Following Tirzepatide Exposure: A Case Report

BACKGROUND AND PURPOSE: Lumbosacral radiculoplexus neuropathy (LRPN) is an uncommon neuropathic syndrome occurring predominantly in patients with diabetes mellitus, although non-diabetic forms are increasingly recognized. Rare peripheral neuropathies have been reported during glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist [GLP-1RA]) therapy; however, LRPN has not previously been described in this clinical context, particularly in non-diabetic individuals. We describe a well-characterized case of painful non-diabetic LRPN developing following a period of rapid metabolic shift during tirzepatide therapy. CASE PRESENTATION: A 62-year-old man previously treated with tirzepatide for weight loss developed, approximately 8 weeks after discontinuation, acute left-sided low back pain, rapidly progressing to severe neuropathic pain, distal weakness, and sensory loss. MR neurography demonstrated enlargement and contrast enhancement of the left L5 nerve root and sciatic nerve, associated with denervation edema. Electrophysiological studies demonstrated an axonal process consistent with lumbosacral radiculoplexus neuropathy, while cerebrospinal fluid analysis showed albuminocytological dissociation. Classical diabetic-related plexopathy was excluded by normal glucose values; an extensive work-up excluded infectious, neoplastic, paraneoplastic, and systemic inflammatory causes. TREATMENT AND OUTCOME: The patient was treated with intravenous methylprednisolone followed by an oral corticosteroid taper and intensive rehabilitation. At 8-month follow-up, neuropathic pain had completely resolved and plantar flexion had recovered, whereas severe foot dorsiflexion weakness persisted, and the patient walked with a single crutch and an ankle-foot orthosis, consistent with the expected outcome of severe axonal lumbosacral radiculoplexus neuropathy. DISCUSSION AND CONCLUSIONS: Tirzepatide exposure was associated with rapid weight loss in a normoglycaemic individual. This case highlights a severe non-diabetic lumbosacral radiculoplexus neuropathy following a period of rapid metabolic shift during GLP-1RA therapy. Although causality cannot be established, the temporal association and clinical context raise the hypothesis that abrupt metabolic changes may act as a permissive factor for immune-mediated lumbosacral plexus injury in susceptible individuals.

Authors

Institutions

Publication Details

Journal
Journal of the Peripheral Nervous System
Published
2026-11-17
DOI
https://doi.org/10.1111/jns.70188
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Painful Non‐Diabetic Lumbosacral Radiculoplexus Neuropathy Following Tirzepatide Exposure: A Case Report

Andrea Pilotto, Loris Poli, Massimiliano Filosto, Roberto Gasparotti et al.
Journal of the Peripheral Nervous System
Peripheral Neuropathies and Disorders
article

Painful Non‐Diabetic Lumbosacral Radiculoplexus Neuropathy Following Tirzepatide Exposure: A Case Report

Andrea Pilotto, Loris Poli, Massimiliano Filosto, Roberto Gasparotti, Luciano Bissolotti, Ugo Leggio, Virginia Bozzoni, Alessandro Padovani, Liberato Stabile
article en

Abstract

BACKGROUND AND PURPOSE: Lumbosacral radiculoplexus neuropathy (LRPN) is an uncommon neuropathic syndrome occurring predominantly in patients with diabetes mellitus, although non-diabetic forms are increasingly recognized. Rare peripheral neuropathies have been reported during glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist [GLP-1RA]) therapy; however, LRPN has not previously been described in this clinical context, particularly in non-diabetic individuals. We describe a well-characterized case of painful non-diabetic LRPN developing following a period of rapid metabolic shift during tirzepatide therapy. CASE PRESENTATION: A 62-year-old man previously treated with tirzepatide for weight loss developed, approximately 8 weeks after discontinuation, acute left-sided low back pain, rapidly progressing to severe neuropathic pain, distal weakness, and sensory loss. MR neurography demonstrated enlargement and contrast enhancement of the left L5 nerve root and sciatic nerve, associated with denervation edema. Electrophysiological studies demonstrated an axonal process consistent with lumbosacral radiculoplexus neuropathy, while cerebrospinal fluid analysis showed albuminocytological dissociation. Classical diabetic-related plexopathy was excluded by normal glucose values; an extensive work-up excluded infectious, neoplastic, paraneoplastic, and systemic inflammatory causes. TREATMENT AND OUTCOME: The patient was treated with intravenous methylprednisolone followed by an oral corticosteroid taper and intensive rehabilitation. At 8-month follow-up, neuropathic pain had completely resolved and plantar flexion had recovered, whereas severe foot dorsiflexion weakness persisted, and the patient walked with a single crutch and an ankle-foot orthosis, consistent with the expected outcome of severe axonal lumbosacral radiculoplexus neuropathy. DISCUSSION AND CONCLUSIONS: Tirzepatide exposure was associated with rapid weight loss in a normoglycaemic individual. This case highlights a severe non-diabetic lumbosacral radiculoplexus neuropathy following a period of rapid metabolic shift during GLP-1RA therapy. Although causality cannot be established, the temporal association and clinical context raise the hypothesis that abrupt metabolic changes may act as a permissive factor for immune-mediated lumbosacral plexus injury in susceptible individuals.

Journal of the Peripheral Nervous SystemVol. 31(4)
Karolinska Institutet (SE), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), University of Brescia (IT)
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon